Prelude Capital Management, LLC Bio Techne Corp Transaction History

Prelude Capital Management, LLC

$1.57 Billion
Q3 2024

A detailed history of Prelude Capital Management, LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Prelude Capital Management, LLC holds 3,512 shares of TECH stock, worth $237,305. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,512

Previous 3,512 -0.0%

Holding current value

$237,305

Previous $280,000 -0.0%

% of portfolio

0.02%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$70.96 - $82.35 $1.12 Million - $1.3 Million	-15,810 Reduced 81.82%	3,512 $280,000
Q2 2024 Aug 14, 2024	SELL	$62.12 - $84.15 $407,134 - $551,519	-6,554 Reduced 25.33%	19,322 $1.38 Million
Q1 2024 May 15, 2024	BUY	$65.98 - $77.09 $955,522 - $1.12 Million	14,482 Added 127.1%	25,876 $1.82 Million
Q4 2023 Feb 14, 2024	BUY	$52.83 - $78.22 $243,176 - $360,046	4,603 Added 67.78%	11,394 $879,000
Q3 2023 Nov 14, 2023	BUY	$67.52 - $89.42 $458,528 - $607,251	6,791 New	6,791 $462,000
Q4 2021 Feb 14, 2022	SELL	$456.15 - $525.06 $496,747 - $571,790	-1,089 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$444.87 - $538.88 $484,463 - $586,840	1,089 New	1,089 $528,000
Q1 2021 May 17, 2021	SELL	$314.62 - $411.0 $480,110 - $627,186	-1,526 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$246.9 - $321.87 $376,769 - $491,173	1,526 New	1,526 $485,000
Q3 2018 Nov 14, 2018	SELL	$147.44 - $204.11 $29,488 - $40,822	-200 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$144.9 - $165.58 $28,980 - $33,116	200 New	200 $30,000
Q4 2017 Feb 14, 2018	SELL	$121.17 - $134.75 $312,618 - $347,655	-2,580 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$113.59 - $123.78 $293,062 - $319,352	2,580	2,580 $312,000

Others Institutions Holding TECH

# of Institutions

603

Shares Held

151M

Call Options Held

195K

Put Options Held

53.2K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.65B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Account

Prelude Capital Management, LLC Bio Techne Corp Transaction History